By Stephanie Brown HealthDay ReporterMONDAY, June 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...

Millions of Americans suffer from dry eye disease, an often-overlooked condition that can significantly impact daily life. In ...

(Reuters) -Eye-care drugmaker Alcon said on Wednesday that the U.S. Food and Drug Administration has approved its treatment ...

I live with lacrimal gland failure, corneal neuralgia, and meibomian gland dysfunction—also known as dry eye. These diseases ...

Dr. Noaman Sanni, a leading ophthalmologist and CEO of Center for Sight New York, has witnessed significant patient and ...

The FDA approved Tryptyr to treat the signs and symptoms of dry eye disease, according to a press release from Alcon. Tryptyr ...

The FDA has approved Tryptyr (acoltremon) as the first TRPM8-targeting eye drop for dry eye disease, stimulating natural tear ...

Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms ...

Alcon, a global eye care company known for products such as Systane and GenTeal Tears, plans to launch Tryptyr in the U.S.

In this episode of CT BUZZ, Reporter Jillian Andrews sat down with Dr. Donald Higgins, Optometrist and Medical Director of ...

Tear film stability, tear production, ocular surface health, and symptoms were all significantly improved with the use of ...